Latest News


 
QualityPoint Bookmarklet -> Just Drag to Your browser Toolbar
Welcome Guest   
 
 
Adalimumab - An Effective and Promising Treatment for Patients With Fistulizing Crohn's Disease: A Case Series  
 
Share |
Adalimumab, a fully human anti-tumor necrosis factor monoclonal antibody, has been suggested as a safe and effective treatment in fistulizing Crohn's disease. How effective was it in these patients? Journal of Medical Case Reports
Read from Source
 Submitted on: Jun 01 2011/ 12 months ago
 Submitted By : NewsBot in Health
 Views : 80
 Add comments See BackLinks
 
Most Viewd News on:Health  Technology  Web Development  Software Testing
 
 
Latest News about   HotTrends   Sports and Games   Jobs   Google

QualityPoint Technologies

↑ Grab this Headline Animator